This menu provides the list of EV proteins identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
UniProt accession
UniProt name
Protein name
Gene symbol
Species
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Homo sapiens
Mus musculus
In vitro/In vivo
Ex vivo
In vitro
In vivo
By sample type
Amnion epithelial cell
Amniotic fluid
Amniotic fluid stem cell
Aqueous humor of age-related macular degeneration
Ascites
B cell (RN (HLA-DR15))
Blood
Bone marrow aspirate
Bone marrow stromal cell
Bone marrow-derived mesenchymal stem cell (MSC)
Brain
Breast cancer cell (BT549)
Breast cancer cell (HS 578T)
Breast cancer cell (MCF-7)
Breast cancer cell (MCF7)
Breast cancer cell (MDA-MB-231)
Breast cancer cell (MDA-MB-468)
Breast cancer cell (T-47D)
Breast milk
Bronchial epithelial cell (30KT)
Carotid atherosclerotic plaque
Central nervous system cancer cell (SF268)
Central nervous system cancer cell (SF295)
Central nervous system cancer cell (SF539)
Central nervous system cancer cell (SNB-19)
Central nervous system cancer cell (SNB-75)
Central nervous system cancer cell (U251)
Cerebrospinal fluid
Cervical cancer (HeLa)
Choriocarcinoma cell (JEG3)
Chronic lymphoid leukemia cell (MEC-1)
Chronic myeloid leukemia (K562)
Colon cancer cell (Colo205)
Colon cancer cell (HCC 2998)
Colon cancer cell (HCT-116)
Colon cancer cell (HCT-15)
Colon cancer cell (HT29)
Colon cancer cell (KM12)
Colon cancer cell (SW480)
Colon cancer cell (SW620)
Colorectal cancer cell (HT29)
Colorectal cancer cell (LIM1215)
Colorectal cancer cell (SW480)
Colorectal cancer cell (SW620)
Colorectal cancer cells (HCT116, DLD1, SW480, SW620)
Dendritic cell
Dermal fibroblast (HDF)
Embryonic kidney cell (293T)
Embryonic kidney cell (HEK293)
Embryonic kidney cell (HEK293T)
Embryonic kidney cells (293T)
Embryonic stem cell derived mesenchymal stem cell
Endothelial cell (HMEC-1)
Endothelial progenitor cell
Epithelial ovarian carcinoma cell (OVCAR3, OVCAR433, OVCAR5 , SKOV3)
Erythrocyte
Expressed prostatic secretions in urine
Extravillous trophoblast cell (HTR8/SVneo)
Glioblastoma cell (U87)
Hepatic stellate cell
Hepatocellular carcinoma cell (Hep3B)
Hepatocellular carcinoma cell (Huh7)
Hepatocellular carcinoma cell (LM3)
Hepatoma cell (Huh-7)
Keratinocyte
Kidney cancer cell (786-O)
Kidney cancer cell (A498)
Kidney cancer cell (ACHN)
Kidney cancer cell (CAKI)
Kidney cancer cell (RXF 393)
Kidney cancer cell (SN12C)
Kidney cancer cell (TK-10)
Kidney cancer cell (UO-31)
Leukemia cell (CCRF-CEM)
Leukemia cell (HL-60)
Leukemia cell (K562)
Leukemia cell (MOLT-4)
Leukemia cell (RPMI-8226)
Leukemia cell (SR)
Leukopak
Lung cancer cell (A549)
Lung cancer cell (HOP-62)
Lung cancer cell (HOP-92)
Lung cancer cell (NCI-H226)
Lung cancer cell (NCI-H23)
Lung cancer cell (NCI-H322M)
Lung cancer cell (NCI-H460)
Lung cancer cell (NCI-H522)
Lung cancer pleural effusion
Lung epithelial cell (E10)
Macrophage
Macrophage (THP1)
Mammary epithelial cell (MCF10A)
Melanocyte
Melanoma cell (1205Lu)
Melanoma cell (501mel)
Melanoma cell (A375M)
Melanoma cell (B16-F10, SK-MEL-202, SK-MEL035, SK-MEL-265)
Melanoma cell (Daju)
Melanoma cell (G1)
Melanoma cell (LOX IMVI)
Melanoma cell (M14)
Melanoma cell (MALME-3M)
Melanoma cell (MDA-MB-435)
Melanoma cell (MNT-1)
Melanoma cell (SK-MEL-2)
Melanoma cell (SK-MEL-28)
Melanoma cell (SK-MEL-5)
Melanoma cell (SKMEL28)
Melanoma cell (UACC-257)
Melanoma cell (UACC-62)
Mesenchymal stem cell
Mesothelioma cell (JO38)
Middle-ear epithelial cell (HMEEC-1)
Monocyte (THP-1)
Monocyte-derived macrophage
Monocyte-derived macrophages
Nasal lavage
Neonatal myoblast cell
Neuroblastoma cell (CHLA255)
Neuroblastoma cell (HTLA-230)
Neuroblastoma cell (IGR-N91)
Neuroblastoma cell (IGR-NB8)
Neuroblastoma cell (IMR32)
Neuroblastoma cell (LAN-1)
Neuroblastoma cell (SH-SY5Y)
Neuroblastoma cell (SK-N-SH)
Neuroblastoma cell (SKNBe2c)
Neutrophil
Non small cell lung cancer (A549)
Non small cell lung cancer (HCC827)
Normal B cell (BJAB)
Normal bronchial epithelial cell (HBE4)
Oral squamous cell carcinoma cell (BHY)
Osteosarcoma cell (MG63)
Osteosarcoma cell (SAOS-2)
Osteosarcoma cell (U2OS)
Ovarian cancer (OVCA429)
Ovarian cancer cell (IGROV1)
Ovarian cancer cell (NCI-ADR-RES)
Ovarian cancer cell (OVCAR-3)
Ovarian cancer cell (OVCAR-4)
Ovarian cancer cell (OVCAR-5)
Ovarian cancer cell (OVCAR-8)
Ovarian cancer cell (SK-OV-3)
Pancreatic ductal adenocarcinoma cell (Pa03C)
Pancreatic ductal adenocarcinoma cell (Pa21C)
Pancreatic ductal adenocarcinoma cell (Pa28C)
Pancreatic ductal epithelial cell (HPNE)
Peritoneal dialysis effluent
Placental mesenchymal stem cell
Placental villous tissue
Plasma
Platelet
Platelet-poor plasma
Prostate cancer cell (DU145)
Prostate cancer cell (DuCaP)
Prostate cancer cell (LNCaP)
Red blood cell
Retinal pigment epithelial cell (RPE-1)
Seminal plasma
Serum
T cells (ED40515(-))
Thymus
Urinary bladder transitional cell carcinoma (FL3)
Urinary bladder transitional cell carcinoma (SLT4)
Urinary bladder transitional cell carcinoma (T24)
Urine
W8B2+ cardiac stem cell
Whole blood
By sample status
Androgen-deprived
Bioreactor culture
Breast cancer-bronchiectasis non-tuberculosis Mycobacterium-infected
Bronchiectasis non-tuberculosis Mycobacterium-infected
CD63-CRISPR
CHAPS-treated
Cell-mediated rejection
Centrifugation
Cholera toxin B-bound
Cholera toxin B-depleted
Chondroitin sulfate-treated
Cocultured with C. albicans
Colorectal cancer
Control
Control_24 h
Control_48 h
Curcumin-treated
Cystinuria patients, molecular weight fractionation
Cystinuria patients, pI fractionation
DTT-treated
Deoxyelephantopin (DET)-treated
Deoxyelephantopin derivative-35 (DETD-35)-treated
Differentiated
Dihydrotestosterone-treated
Docetaxel-resistant
Docetaxel-sensitive
Donor 1 (Exo-Spin)
Donor 1 (SEC fraction 7+8)
Donor 2 (Exo-Spin)
Donor 3 (Exo-Spin)
Donor 3 (SEC fraction 8)
Doxorubicin-treated
Exosomes
F3-10K
F5-100K
F5-10K
Flask culture
HIV-1-infected_Exosome
HTLV-1-infected, Tax-negative
Healthy
Helicobacter pylori-infected
High-grade bladder cancer
High-risk prostate cancer (Gleason score 8-9)
Hypertensive patients under chronic suppression of RAS
Hypoxic condition
IL3-Lamp2b-transfected
Idiopathic longitudinally extensive transverse myelitis
Influenza A virus-infected
Insulin-induced
Irradiated (6 Gy)
Lacunar infarction-cognitive decline without recurrent vascular events
Lacunar infarction-no adverse outcome
Lacunar infarction-recurrent vascular events
Low-grade prostate cancer patient
Low-risk prostate cancer (Gleason score 6)
Low-sulfated hyaluronic acid-treated
M. tuberculosis-infected
Mature milk
Microvesicle, Storage day 3
Microvesicles
Multiple myeloma
Multiple sclerosis
Mycobacterium tuberculosis-infected_Orbitrap
Mycobacterium tuberculosis-infected_QSTAR
Nanovesicle, Storage day 21
Nanovesicle, Storage day 3
Nanovesicle, Storage day 42
Neuromyelitis optica
Non-small cell lung cancer patient
Non-sulfated hyaluronic acid-treated
Nontypeable Haemophilus influenzae lysate-treated_24 h
Nontypeable Haemophilus influenzae lysate-treated_48 h
Normal
Normal donors
Normal donors and patients of deep venous thrombosis
Normal_Annexin V-binding EVs
Normal_Orbitrap
Normal_QSTAR
Normal_Ultracentrifugation
Oxidative stress
P. falciparum-infected
PDGF-BB-treated
PEG precipitation
Parkinson's disease patient
Patient of developmental heart defect_exosome
Patient of developmental heart defect_microparticle
Patients of basement membrane nephropathy
Patients of bladder cancer
Patients of carotid atherosclerosis
Patients of colorectal cancer
Patients of external counterpulsation therapy
Preeclampsia patients
Preeclampsia_Annexin V-binding EVs
Preeclampsia_Cholera toxin part B-binding EVs
Protein organic solvent precipitation
Radiation
ST-eleavated myocardial infarction
Size exclusion chromatography
Stimulated by IgG
Stimulated in immobile phase
Stimulated with beta-glucan
Stressed (hypoxia, TNF-慣-induced activation, high glucose and mannose concentrations)
TGF-β-treated
Trauma patients
Tubular injury
Ultra-cushion
Ultracentrifugation
p53 knock-down and EGFR L858R point mutation
pCMV-HA-HBx-transfected
pCMV-HBV1.1(X')-transfected
pCMV-HBV1.1-transfected
pCMV-transfected
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Protein name
UniProt accession
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
Apolipoprotein E (Apo-E)
P02649
Microparticles released from Mycobacterium tuberculosis-infected human macrophages contain increased levels of the type I interferon inducible proteins including ISG15.
Proteomics. 2015 Jun 2. doi: 10.1002/pmic.201400610.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts.
Blood. 2015 Jun 22. pii: blood-2014-12-618025.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Exosomes released by keratinocytes modulate melanocyte pigmentation.
Nat Commun. 2015 Jun 24;6:7506. doi: 10.1038/ncomms8506.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer.
Nature. 2015 Jun 24. doi: 10.1038/nature14581.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer.
Nature. 2015 Jun 24. doi: 10.1038/nature14581.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer.
Nature. 2015 Jun 24. doi: 10.1038/nature14581.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer.
Nature. 2015 Jun 24. doi: 10.1038/nature14581.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Size-exclusion chromatography as a stand-alone methodology identifies novel markers in mass spectrometry analyses of plasma-derived vesicles from healthy individuals.
J Extracell Vesicles. 2015 Jul 6;4:27378. doi: 10.3402/jev.v4.27378. eCollection 2015.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Size-exclusion chromatography as a stand-alone methodology identifies novel markers in mass spectrometry analyses of plasma-derived vesicles from healthy individuals.
J Extracell Vesicles. 2015 Jul 6;4:27378. doi: 10.3402/jev.v4.27378. eCollection 2015.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Size-exclusion chromatography as a stand-alone methodology identifies novel markers in mass spectrometry analyses of plasma-derived vesicles from healthy individuals.
J Extracell Vesicles. 2015 Jul 6;4:27378. doi: 10.3402/jev.v4.27378. eCollection 2015.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Size-exclusion chromatography as a stand-alone methodology identifies novel markers in mass spectrometry analyses of plasma-derived vesicles from healthy individuals.
J Extracell Vesicles. 2015 Jul 6;4:27378. doi: 10.3402/jev.v4.27378. eCollection 2015.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Size-exclusion chromatography as a stand-alone methodology identifies novel markers in mass spectrometry analyses of plasma-derived vesicles from healthy individuals.
J Extracell Vesicles. 2015 Jul 6;4:27378. doi: 10.3402/jev.v4.27378. eCollection 2015.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Exosomal clusterin, identified in the pericardial fluid, improves myocardial performance following MI through epicardial activation, enhanced arteriogenesis and reduced apoptosis.
Int J Cardiol. 2015 Jun 14;197:333-347. doi: 10.1016/j.ijcard.2015.06.008.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Extracellular vesicles are rapidly purified from human plasma by PRotein Organic Solvent PRecipitation (PROSPR).
Sci Rep. 2015 Sep 30;5:14664. doi: 10.1038/srep14664.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Extracellular vesicles are rapidly purified from human plasma by PRotein Organic Solvent PRecipitation (PROSPR).
Sci Rep. 2015 Sep 30;5:14664. doi: 10.1038/srep14664.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Osteoblast-released matrix vesicles - regulation of activity and composition by sulfated and non-sulfated glycosaminoglycans.
Mol Cell Proteomics. 2015 Nov 23. pii: mcp.M115.049718.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Osteoblast-released matrix vesicles - regulation of activity and composition by sulfated and non-sulfated glycosaminoglycans.
Mol Cell Proteomics. 2015 Nov 23. pii: mcp.M115.049718.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Osteoblast-released matrix vesicles - regulation of activity and composition by sulfated and non-sulfated glycosaminoglycans.
Mol Cell Proteomics. 2015 Nov 23. pii: mcp.M115.049718.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Osteoblast-released matrix vesicles - regulation of activity and composition by sulfated and non-sulfated glycosaminoglycans.
Mol Cell Proteomics. 2015 Nov 23. pii: mcp.M115.049718.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Exosomes as nanocarriers for systemic delivery of the Helicobacter pylori virulence factor CagA.
Sci Rep. 2016 Jan 7;6:18346. doi: 10.1038/srep18346.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Exosomes as nanocarriers for systemic delivery of the Helicobacter pylori virulence factor CagA.
Sci Rep. 2016 Jan 7;6:18346. doi: 10.1038/srep18346.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Triple SILAC quantitative proteomic analysis reveals differential abundance of cell signaling proteins between normal and lung cancer-derived exosomes.
J Proteomics. 2015 Dec 28. pii: S1874-3919(15)30222-0. doi: 10.1016/j.jprot.2015.12.023.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Triple SILAC quantitative proteomic analysis reveals differential abundance of cell signaling proteins between normal and lung cancer-derived exosomes.
J Proteomics. 2015 Dec 28. pii: S1874-3919(15)30222-0. doi: 10.1016/j.jprot.2015.12.023.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Triple SILAC quantitative proteomic analysis reveals differential abundance of cell signaling proteins between normal and lung cancer-derived exosomes.
J Proteomics. 2015 Dec 28. pii: S1874-3919(15)30222-0. doi: 10.1016/j.jprot.2015.12.023.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers.
J Proteomics. 2016 Jan 13. pii: S1874-3919(15)30214-1. doi: 10.1016/j.jprot.2015.12.016.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers.
J Proteomics. 2016 Jan 13. pii: S1874-3919(15)30214-1. doi: 10.1016/j.jprot.2015.12.016.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers.
J Proteomics. 2016 Jan 13. pii: S1874-3919(15)30214-1. doi: 10.1016/j.jprot.2015.12.016.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers.
J Proteomics. 2016 Jan 13. pii: S1874-3919(15)30214-1. doi: 10.1016/j.jprot.2015.12.016.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Circular RNAs co-precipitate with extracellular vesicles: a possible mechanism for circRNA clearance.
PLoS One. 2016 Feb 5;11(2):e0148407. doi: 10.1371/journal.pone.0148407. eCollection 2016.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Fibronectin-Containing Extracellular Vesicles Protect Melanocytes Against Ultraviolet Radiation-Induced Cytotoxicity.
J Invest Dermatol. 2016 Feb 5. pii: S0022-202X(16)00461-9. doi: 10.1016/j.jid.2015.08.001.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes.
Proc Natl Acad Sci U S A. 2016 Feb 8. pii: 201521230.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes.
Proc Natl Acad Sci U S A. 2016 Feb 8. pii: 201521230.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes.
Proc Natl Acad Sci U S A. 2016 Feb 8. pii: 201521230.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Exosomes mediated pentose phosphate pathway in ovarian cancer metastasis: a proteomics analysis.
Int J Clin Exp Pathol. 2015 Dec 1;8(12):15719-28. eCollection 2015.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
MSC secretes at least 3 EV types each with a unique permutation of membrane lipid, protein and RNA.
J Extracell Vesicles. 2016 Feb 24;5:29828. doi: 10.3402/jev.v5.29828. eCollection 2016.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
MSC secretes at least 3 EV types each with a unique permutation of membrane lipid, protein and RNA.
J Extracell Vesicles. 2016 Feb 24;5:29828. doi: 10.3402/jev.v5.29828. eCollection 2016.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Curcumin modulates chronic myelogenous leukemia exosomes composition and affects angiogenic phenotype, via exosomal miR-21.
Oncotarget. 2016 Mar 30. doi: 10.18632/oncotarget.8483.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Curcumin modulates chronic myelogenous leukemia exosomes composition and affects angiogenic phenotype, via exosomal miR-21.
Oncotarget. 2016 Mar 30. doi: 10.18632/oncotarget.8483.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Enrichment of extracellular vesicles from tissues of the central nervous system by PROSPR.
Mol Neurodegener. 2016 May 23;11(1):41. doi: 10.1186/s13024-016-0108-1.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Effective isolation of exosomes with polyethylene glycol from cell culture supernatant for in-depth proteome profiling.
Analyst. 2016 May 27.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Exosomes in the nose induce immune cell trafficking and harbour an altered protein cargo in chronic airway inflammation.
J Transl Med. 2016 Jun 20;14(1):181. doi: 10.1186/s12967-016-0927-4.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Amnion-Epithelial-Cell-Derived Exosomes Demonstrate Physiologic State of Cell under Oxidative Stress.
PLoS One. 2016 Jun 22;11(6):e0157614. doi: 10.1371/journal.pone.0157614. eCollection 2016.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Amnion-Epithelial-Cell-Derived Exosomes Demonstrate Physiologic State of Cell under Oxidative Stress.
PLoS One. 2016 Jun 22;11(6):e0157614. doi: 10.1371/journal.pone.0157614. eCollection 2016.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic Analysis of Exosomes and Exosome-Free Conditioned Media Derived from Human Osteosarcoma Cell Lines Reveal Differential Secretion of Proteins Related to Biological Functions and Tumor Progression.
J Cell Biochem. 2016 Jun 30. doi: 10.1002/jcb.25642.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic Analysis of Exosomes and Exosome-Free Conditioned Media Derived from Human Osteosarcoma Cell Lines Reveal Differential Secretion of Proteins Related to Biological Functions and Tumor Progression.
J Cell Biochem. 2016 Jun 30. doi: 10.1002/jcb.25642.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic Analysis of Exosomes and Exosome-Free Conditioned Media Derived from Human Osteosarcoma Cell Lines Reveal Differential Secretion of Proteins Related to Biological Functions and Tumor Progression.
J Cell Biochem. 2016 Jun 30. doi: 10.1002/jcb.25642.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Comparative proteomic analysis of extracellular vesicles isolated by acoustic trapping or differential centrifugation.
Anal Chem. 2016 Aug 3.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Comparative proteomic analysis of extracellular vesicles isolated by acoustic trapping or differential centrifugation.
Anal Chem. 2016 Aug 3.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Comparative proteomic analysis of extracellular vesicles isolated by acoustic trapping or differential centrifugation.
Anal Chem. 2016 Aug 3.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Comparative proteomic analysis of extracellular vesicles isolated by acoustic trapping or differential centrifugation.
Anal Chem. 2016 Aug 3.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer.
Oncotarget. 2016 Aug 8. doi: 10.18632/oncotarget.11111.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer.
Oncotarget. 2016 Aug 8. doi: 10.18632/oncotarget.11111.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer.
Oncotarget. 2016 Aug 8. doi: 10.18632/oncotarget.11111.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer.
Oncotarget. 2016 Aug 8. doi: 10.18632/oncotarget.11111.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Efficient production and enhanced tumor delivery of engineered extracellular vesicles.
Biomaterials. 2016 Jul 6;105:195-205. doi: 10.1016/j.biomaterials.2016.07.003.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Efficient production and enhanced tumor delivery of engineered extracellular vesicles.
Biomaterials. 2016 Jul 6;105:195-205. doi: 10.1016/j.biomaterials.2016.07.003.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo.
Sci Rep. 2016 Sep 8;6:32643. doi: 10.1038/srep32643.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Exosomal proteome analysis of cerebrospinal fluid detects biosignatures of neuromyelitis optica and multiple sclerosis.
Clin Chim Acta. 2016 Sep 5. pii: S0009-8981(16)30375-8. doi: 10.1016/j.cca.2016.09.001.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Exosomal proteome analysis of cerebrospinal fluid detects biosignatures of neuromyelitis optica and multiple sclerosis.
Clin Chim Acta. 2016 Sep 5. pii: S0009-8981(16)30375-8. doi: 10.1016/j.cca.2016.09.001.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Exosomal proteome analysis of cerebrospinal fluid detects biosignatures of neuromyelitis optica and multiple sclerosis.
Clin Chim Acta. 2016 Sep 5. pii: S0009-8981(16)30375-8. doi: 10.1016/j.cca.2016.09.001.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Identification and Characterization of 293T Cell-Derived Exosomes by Profiling the Protein, mRNA and MicroRNA Components.
PLoS One. 2016 Sep 20;11(9):e0163043. doi: 10.1371/journal.pone.0163043. eCollection 2016.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic and bioinformatic characterization of extracellular vesicles released from human macrophages upon influenza A virus infection.
J Proteome Res. 2016 Oct 11.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic and bioinformatic characterization of extracellular vesicles released from human macrophages upon influenza A virus infection.
J Proteome Res. 2016 Oct 11.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Candida albicans Modifies the Protein Composition and Size Distribution of THP1 macrophages-derived Extracellular Vesicles.
J Proteome Res. 2016 Oct 14.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Candida albicans Modifies the Protein Composition and Size Distribution of THP1 macrophages-derived Extracellular Vesicles.
J Proteome Res. 2016 Oct 14.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression.
Eur J Pharm Sci. 2016 Oct 14. pii: S0928-0987(16)30431-6. doi: 10.1016/j.ejps.2016.10.008.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression.
Eur J Pharm Sci. 2016 Oct 14. pii: S0928-0987(16)30431-6. doi: 10.1016/j.ejps.2016.10.008.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Mycobacterium tuberculosis Infection Manipulates the Glycosylation Machinery and the N-Glycoproteome of Human Macrophages and their Microparticles.
J Proteome Res. 2016 Oct 19.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Mycobacterium tuberculosis Infection Manipulates the Glycosylation Machinery and the N-Glycoproteome of Human Macrophages and their Microparticles.
J Proteome Res. 2016 Oct 19.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.
J Extracell Vesicles. 2016 Nov 17;5:32570. doi: 10.3402/jev.v5.32570. eCollection 2016.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.
J Extracell Vesicles. 2016 Nov 17;5:32570. doi: 10.3402/jev.v5.32570. eCollection 2016.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.
J Extracell Vesicles. 2016 Nov 17;5:32570. doi: 10.3402/jev.v5.32570. eCollection 2016.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.
J Extracell Vesicles. 2016 Nov 17;5:32570. doi: 10.3402/jev.v5.32570. eCollection 2016.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.
J Extracell Vesicles. 2016 Nov 17;5:32570. doi: 10.3402/jev.v5.32570. eCollection 2016.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.
J Extracell Vesicles. 2016 Nov 17;5:32570. doi: 10.3402/jev.v5.32570. eCollection 2016.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Application of nano-LC-MALDI-TOF/TOF-MS for proteomic analysis of microvesicles.
Clin Biochem. 2016 Nov 16. pii: S0009-9120(16)30570-7. doi: 10.1016/j.clinbiochem.2016.11.013.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC
347
/
0
/
347
Apolipoprotein E (Apo-E)
P02649
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers.
Oncotarget. 2016 Nov 24. doi: 10.18632/oncotarget.13569.
ENOG4111MYC
347
/
0
/
347
<
[2]
[3]